{"database": "lobbying", "table": "lobbying_activities", "rows": [[2819796, "9af5225f-3314-47dc-8f4b-6e5edb9d6c74", "Q2", "MARSHALL & POPP, LLC", 401105121, "BUTTERFLY NETWORK, INC.", 2022, "second_quarter", "SCI", "Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act. Issues related to FDA regulation of medical devices, including S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2022-07-15T00:38:34-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2819796"], "units": {}, "query_ms": 31.704912951681763, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}